DE69027031T2 - Nicht glycosierte proteine, analoge des menschlichen interleukin-3 - Google Patents

Nicht glycosierte proteine, analoge des menschlichen interleukin-3

Info

Publication number
DE69027031T2
DE69027031T2 DE69027031T DE69027031T DE69027031T2 DE 69027031 T2 DE69027031 T2 DE 69027031T2 DE 69027031 T DE69027031 T DE 69027031T DE 69027031 T DE69027031 T DE 69027031T DE 69027031 T2 DE69027031 T2 DE 69027031T2
Authority
DE
Germany
Prior art keywords
glycosized
analogs
proteins
human interleukin
urticaria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69027031T
Other languages
English (en)
Other versions
DE69027031D1 (de
Inventor
David Urdal
Helmut Sassenfeld
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunex Corp
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of DE69027031D1 publication Critical patent/DE69027031D1/de
Publication of DE69027031T2 publication Critical patent/DE69027031T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5403—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/823—Lower fungi, e.g. mold
    • Y10S530/824—Yeasts
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/141—Interleukin
DE69027031T 1989-06-30 1990-06-13 Nicht glycosierte proteine, analoge des menschlichen interleukin-3 Expired - Fee Related DE69027031T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/374,667 US5128450A (en) 1989-06-30 1989-06-30 Nonglycosylated human interleukin-3 analog proteins
PCT/US1990/003345 WO1991000350A1 (en) 1989-06-30 1990-06-13 Nonglycosylated human interleukin-3 analog proteins

Publications (2)

Publication Number Publication Date
DE69027031D1 DE69027031D1 (de) 1996-06-20
DE69027031T2 true DE69027031T2 (de) 1996-12-19

Family

ID=23477728

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69027031T Expired - Fee Related DE69027031T2 (de) 1989-06-30 1990-06-13 Nicht glycosierte proteine, analoge des menschlichen interleukin-3

Country Status (12)

Country Link
US (1) US5128450A (de)
EP (1) EP0482013B1 (de)
JP (1) JPH04506342A (de)
AT (1) ATE138099T1 (de)
AU (1) AU630207B2 (de)
CA (1) CA2033182A1 (de)
DE (1) DE69027031T2 (de)
DK (1) DK0482013T3 (de)
ES (1) ES2090135T3 (de)
FI (1) FI916077A0 (de)
NO (1) NO301482B1 (de)
WO (1) WO1991000350A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5328988A (en) * 1987-10-26 1994-07-12 Immunex Corporation Interleukin-7
US5714585A (en) * 1987-10-26 1998-02-03 Sterling Winthrop, Inc. Antibodies that are immunoreactive with interleukin-7
US5705362A (en) * 1992-05-25 1998-01-06 Gist-Brocades, N.V. Modified signal sequences
US5463029A (en) * 1992-11-23 1995-10-31 Immunex Corporation Purification of fusion proteins comprising GM-CSF and IL-3
US6361976B1 (en) 1992-11-24 2002-03-26 S. Christopher Bauer Co-administration of interleukin-3 mutant polypeptides with CSF'S for multi-lineage hematopoietic cell production
US6403076B1 (en) 1992-11-24 2002-06-11 S. Christopher Bauer Compositions for increasing hematopoiesis with interleukin-3 mutants
US5772992A (en) * 1992-11-24 1998-06-30 G.D. Searle & Co. Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors
US6153183A (en) * 1992-11-24 2000-11-28 G. D. Searle & Company Co-administration of interleukin-3 mutant polypeptides with CSF's or cytokines for multi-lineage hematopoietic cell production
EP0672145B1 (de) * 1992-11-24 2003-04-23 G.D. Searle & Co. Interleukin-3 (il-3)-polypeptide mith mehreren mutationen
US5738849A (en) * 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
US5501962A (en) * 1993-06-21 1996-03-26 G. D. Searle & Co. Interleuken-3 (IL-3) human/murine hybrid polypeptides and recombinant production of the same
CA2176115A1 (en) * 1993-11-10 1995-05-18 Clifford M. Snapper Compositions and method for stimulating antibody release by b lymphocytes
US6017523A (en) * 1995-06-06 2000-01-25 G.D. Searle & Co. Therapeutic methods employing mutant human interleukin-3 (IL-3) polypeptides
DE60036915T2 (de) 1999-01-13 2008-08-07 Alchemia Oncology Pty Ltd., Hawthorn Verwendung von hyaluronan zur herstellung eines medikaments zur erhöhung der wirksamkeit von zytotoxischen arzneimitteln
US9066919B2 (en) * 2000-07-14 2015-06-30 Alchemia Oncology Pty Limited Hyaluronan as a chemo-sensitizer in the treatment of cancer
AUPQ879500A0 (en) * 2000-07-14 2000-08-10 Meditech Research Limited Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
WO2002069977A1 (en) 2001-03-01 2002-09-12 Hollis-Eden Pharmaceuticals, Inc. Use of certain steroids for treatment of blood cell deficiencies
EP1427447A4 (de) * 2001-08-27 2007-05-23 Alchemia Oncology Ltd Verbesserte therapieprotokolle
JP4212827B2 (ja) * 2002-05-16 2009-01-21 シスメックス株式会社 骨髄液有核細胞自動分析方法
CA2496867A1 (en) 2002-08-28 2004-03-11 Hollis-Eden Pharmaceuticals, Inc. Therapeutic treatment methods
EP1848738A1 (de) * 2005-01-25 2007-10-31 Apollo Life Sciences Limited Parameterausgewählte gm-csf, il-3, il-4, il-5 und chimären davon für therapeutische und diagnostische zwecke
WO2007012133A1 (en) * 2005-07-27 2007-02-01 Alchemia Oncology Pty Limited Therapeutic protocols using hyaluronan
EA013877B1 (ru) * 2005-09-07 2010-08-30 Алкемиа Онколоджи Пти Лимитед Терапевтические композиции, содержащие гиалуроновую кислоту и терапевтические антитела, а также способы лечения
JP5628544B2 (ja) * 2010-04-07 2014-11-19 株式会社豊田中央研究所 クロストリジウム・サーモセラム由来のタンパク質複合体を構築するためのタンパク質及びその利用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695542A (en) * 1983-10-04 1987-09-22 Dnax Research Institute Of Molecular And Cellular Biology, Inc. cDNA clones coding for polypeptides exhibiting multi-lineage cellular growth factor activity
US4877729A (en) * 1986-07-14 1989-10-31 Genetics Institute, Inc. Recombinant DNA encoding novel family of primate hematopoietic growth factors
IL84852A (en) * 1986-12-16 1994-06-24 Gist Brocades Nv Molecular coding and expression of LI-3
EP0790307A1 (de) * 1986-12-16 1997-08-20 Gist-Brocades B.V. Molekulare Klonierung und Expression von menschlichem IL-3
AU1496688A (en) * 1987-01-20 1988-08-10 Immunex Corporation Human interleukin-3 proteins
OA09736A (en) * 1987-02-18 1993-11-30 Schering Biotech Corp "Human interleukin-3 and muteins thereof".
WO1990001039A1 (en) * 1988-07-20 1990-02-08 Immunex Corporation Nonglycosylated human interleukin-3 compositions

Also Published As

Publication number Publication date
NO915116D0 (no) 1991-12-27
NO301482B1 (no) 1997-11-03
ATE138099T1 (de) 1996-06-15
ES2090135T3 (es) 1996-10-16
EP0482013B1 (de) 1996-05-15
EP0482013A1 (de) 1992-04-29
CA2033182A1 (en) 1990-12-31
US5128450A (en) 1992-07-07
DK0482013T3 (da) 1996-06-03
DE69027031D1 (de) 1996-06-20
FI916077A0 (fi) 1991-12-20
JPH04506342A (ja) 1992-11-05
AU5821690A (en) 1991-01-17
WO1991000350A1 (en) 1991-01-10
AU630207B2 (en) 1992-10-22
NO915116L (no) 1992-02-28

Similar Documents

Publication Publication Date Title
DE69027031T2 (de) Nicht glycosierte proteine, analoge des menschlichen interleukin-3
MXPA02007932A (es) Analogos de nucleosidos con base biciclica modificada con carboxamidina.
IL85523A (en) Stable alpha interferon complex,its preparation and pharmaceutical compositions comprising it
IL95691A0 (en) Thienylcarboxylates of amino alcohols,their preparation and pharmaceutical compositions containing them
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
AU6701890A (en) Process for the production of biologically active protein
PT89534A (pt) Processo para a preparacao de composicoes farmaceuticas anticoagulantes contendo como ingrediente activo proteina c ou proteina c activada combinada com heparina
LV10954A (lv) Benzimidazola atvasinajumi to iegusanas panemiens un tos saturosa farmaceitiska kompozicija
ES2173858T3 (es) Analogos de huperzina a.
ATE192037T1 (de) Verwendung von arginin als immunstimulator
IE882091L (en) Pharmaceutical compositions comprising sometostatin¹analogues
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
MX9703642A (es) Metodos para el tratamiento de esclerosis multiple utilizando analogos de peptido en la posicion 91 de la proteina basica de mielina humana.
IT1299583B1 (it) Uso di proteine hmg-i per la preparazione di medicamenti ad attivita' citotossica
AU2308992A (en) Cysteine depleted il-6 muteins
EP0225020A3 (de) Peptide, welche in der Sequenz Einheiten von Aminosäureresten 17 bis 24 von VIP enthalten
DE69333412D1 (de) Übergangszustand-analoga des kokains, ihre verwendung zur herstellung von kataltischen antikörpern gegen kokain und verwendung derselben in diagnose und therapie
DE69636052D1 (de) Mpl-liganden analoga
DE59001121D1 (en) Antacidatabletten.
WO2004028457A3 (en) PHARMACEUTICAL COMPOSITION FOR IMPROVED ADMINISTRATION OF HIV gp41-DERIVED PEPTIDES, AND ITS USE IN THERAPY
KR960700741A (ko) 인터페론치료에 대한 무응답자의 c형 간염 치료방법(method of treating hepatitis c in non-pesponders to interferon treatment)
ES2032757T3 (es) Inyecciones que contienen alcohol poliprenilico y el uso de estas.
YU64192A (sh) Analozi insulina
AU7618391A (en) Aqueous pharmaceutical formulations of erythropoietin and the use thereof
YU61302A (sh) Analozi nukleozida sa modifikovanom karboksamidinskom bicikličnom bazom

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee